Cargando…
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era
Hepatitis due to hepatitis B virus (HBV) reactivation can be serious and potentially fatal, but is preventable. HBV reactivation is most commonly reported in patients receiving chemotherapy, especially rituximab-containing therapy for hematological malignancies and those receiving stem cell transpla...
Autores principales: | Mak, Joyce Wing Yan, Law, Alvin Wing Hin, Law, Kimmy Wan Tung, Ho, Rita, Cheung, Carmen Ka Man, Law, Man Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507505/ https://www.ncbi.nlm.nih.gov/pubmed/37731995 http://dx.doi.org/10.3748/wjg.v29.i33.4942 |
Ejemplares similares
-
Efficacy of Vaccine Protection Against COVID-19 Virus Infection in Patients with Chronic Liver Diseases
por: Cheung, Carmen Ka Man, et al.
Publicado: (2023) -
Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases
por: Law, Man Fai, et al.
Publicado: (2021) -
Transfusion-transmitted hepatitis E: What we know so far?
por: Cheung, Carmen Ka Man, et al.
Publicado: (2022) -
Update on Molecular Diagnosis in Extranodal NK/T-Cell Lymphoma and Its Role in the Era of Personalized Medicine
por: Sun, Ka-Hei (Murphy), et al.
Publicado: (2022) -
Massive pulmonary embolism in a patient with polysplenia syndrome and interrupted inferior vena cava with azygous continuation
por: Cheung, Carmen K. M., et al.
Publicado: (2017)